Care Advisor
Back to blog
Policy

From Screening to Registration to Treatment Costs — How to Use Dementia Support Programs

If your parent's memory is beginning to fade, the first thing to know is where to get a screening and what support you can apply for. We've laid out Korea's Dementia Care Centers and the U.S. Medicare system step by step.

케어 어드바이저 2026.10.02

Market coverage notice: This article covers resources from both Korea and the United States. Each piece of information is labeled 🇰🇷 Korea or 🇺🇸 U.S. in the text to indicate which country it applies to.

It's natural to feel a heaviness in your heart when a parent starts repeating the same words or frequently gets lost on familiar streets. Yet many families put off a screening — telling themselves, "Surely it can't be that" — only to discover available programs far too late. Dementia can be slowed when it is caught and managed early. And in both Korea and the United States, there are real, step-by-step programs in place covering everything from screening to help with treatment costs.

🇰🇷 Korea The first door for screening is the Dementia Care Center (치매안심센터). Across the country, 256 치매안심센터 locations offer a range of services: early dementia screening, personalized case management, dementia treatment cost support, ID tags for wandering seniors, and public awareness education. Any person aged 60 or older who suspects dementia can visit the 치매안심센터 in their district with just a photo ID and receive a free early screening. The first step — the Cognitive Impairment Screening Test (CIST) — takes about 15 minutes as a one-on-one question-and-answer session, and results are available immediately.

🇰🇷 Korea If the screening raises concern about cognitive decline, the process moves to a second-stage diagnostic evaluation (neuropsychological testing). Testing costs are covered up to 150,000 won. If a dementia diagnosis is confirmed, a third-stage differential examination (blood work, urinalysis, and brain imaging) follows. Support for this differential examination reaches up to 80,000 won at clinics and general hospitals, and up to 110,000 won at tertiary care hospitals. The initial screening itself is free regardless of income — it is not limited to low-income households (those at or below 120% of the standard median income). For seniors who have difficulty traveling, a "home-visit early screening service" goes directly to senior centers, apartment complexes, and welfare facilities.

🇰🇷 Korea After receiving a dementia diagnosis, it is important to register as a patient with the 치매안심센터. Registration opens the door to a wide range of services: dementia treatment cost support, hygiene supplies (조호물품), personalized case management, wandering-detection devices and fingerprint pre-registration to prevent elopement, and connections to family education classes and peer support groups. The dementia treatment cost benefit covers the insured co-payment for dementia medications and the same-day physician visit up to 30,000 won per month, or 360,000 won per year (based on the Ministry of Health and Welfare's 2026 Dementia Policy Program Guidelines). Income eligibility is set at or below 120–140% of the standard median income, depending on the local government. Applications can be submitted in person by the patient or a family member at the community health center (치매안심센터) in the district where the patient is registered.

🇺🇸 U.S. In the United States, Medicare provides the basic framework for dementia-related screening and care. Since 2011, Medicare has included a cognitive function assessment as a free preventive service within the Annual Wellness Visit. During this visit, the physician evaluates cognitive function through direct observation, conversation, and memory tests. If cognitive decline is suspected, the patient is referred for a more detailed neuropsychological evaluation; as of 2026, this involves the Part B annual deductible of $283 followed by a 20% co-payment.

🇺🇸 U.S. After a dementia diagnosis, it is worth paying close attention to the GUIDE Model (Guiding an Improved Dementia Experience), operated by CMS (Centers for Medicare & Medicaid Services). GUIDE is a program for Original Medicare (Part A and B) enrollees whose clinician has confirmed a dementia diagnosis. It bundles care coordination, family education and support, 24-hour clinical support, and respite care costs into a single program. Unpaid family caregivers of patients with severe or advanced dementia can receive up to $2,625 per year in respite service costs, with no out-of-pocket cost to the patient. However, Medicare Advantage enrollees and nursing home residents with stays exceeding 100 days are excluded. Because the program is only available where a participating provider exists, it is best to first confirm GUIDE participation with your physician or care team.

🇺🇸 U.S. New blood-based tests have been developed that can detect Alzheimer's years before symptoms appear, but Medicare currently classifies these tests as screening tests and does not cover them. A bipartisan bill, the ASAP Act (Alzheimer's Screening and Prevention Act), has been introduced in both chambers of Congress to change this, and it is worth watching for future policy developments.

Whether in Korea or the United States, knowing the programs that exist and taking the first step to reach out makes an enormous difference — for your parent and for your whole family. If you have been hesitating because you are not sure where to begin, Sierra Care Advisor is here to help you find the way, in Korean.

Sources: Ministry of Health and Welfare, "2026 Dementia Policy Program Guidelines"; 복지로 (bokjiro.go.kr); 찾기쉬운생활법령정보 (easylaw.go.kr); National Health Insurance Service Health Insurance Webzine; AARP (aarp.org) Medicare Dementia Coverage; Centers for Medicare & Medicaid Services (cms.gov) GUIDE Model; benefitsusa.org, "Medicare Coverage for Alzheimer and Dementia Care 2026"; healthjournalism.org (2026.04.03); U.S. Senate ASAP Act (S.3267, 119th Congress).

Note: This article was compiled by AI from the sources cited above. We strive for accuracy, but for decisions about your specific situation, please confirm the latest guidance from a professional or the relevant agency.

Have a question?

A care advisor will guide you one-on-one, tailored to your situation.

Request a consultation